Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05525767
What this trial is testing

Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer

Who this might be right for
Solid Tumor
Hebei Medical University Fourth Hospital 75
Early research (Phase 1)Study completedNCT01168011
What this trial is testing

Safety, Pharmacokinetics and Clinical Activity of Oral Rigosertib in Solid Tumors

Who this might be right for
Solid Tumor
Traws Pharma, Inc. 68
Early research (Phase 1)Ended earlyNCT00801151
What this trial is testing

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Who this might be right for
Malignant Solid Tumour
Institut Claudius Regaud 30
Early research (Phase 1)Study completedNCT01898845
What this trial is testing

A Phase I Study of LEE011 in Asian Patients

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 17
Testing effectiveness (Phase 2)Looking for participantsNCT05768139
What this trial is testing

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Breast CancerSolid Tumors, Adult
Eli Lilly and Company 880
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Early research (Phase 1)Study completedNCT01023737
What this trial is testing

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
The University of Texas Health Science Center at San Antonio 72
Early research (Phase 1)Looking for participantsNCT06004245
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsColorectal Cancer
Vividion Therapeutics, Inc. 280
Early research (Phase 1)UnknownNCT00005611
What this trial is testing

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT00516802
What this trial is testing

Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Who this might be right for
Melanoma Neoplasms
AstraZeneca 40
Early research (Phase 1)Looking for participantsNCT07101601
What this trial is testing

Study of DM5167 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Breast Cancer
DIGMBIO 58
Very early researchUnknownNCT05287165
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

Who this might be right for
Advanced Solid TumorsDigestive System NeoplasmsPancreatic Cancer Resectable+1 more
Beijing Immunochina Medical Science & Technology Co., Ltd. 19
Early research (Phase 1)Study completedNCT01022853
What this trial is testing

Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors

Who this might be right for
Neoplasms
Boehringer Ingelheim 30
Early research (Phase 1)Study completedNCT00441207
What this trial is testing

Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors

Who this might be right for
Cancer
Midwestern Regional Medical Center 18
Early research (Phase 1)Looking for participantsNCT06764836
What this trial is testing

IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHCC
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 108
Early research (Phase 1)Study completedNCT00276575
What this trial is testing

Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Herbert Hurwitz, MD 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623707
What this trial is testing

FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
FutureGen Biopharmaceutical (Beijing) Co., Ltd 264
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Early research (Phase 1)Looking for participantsNCT07492628
What this trial is testing

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more
Beijing Biotech 42
Testing effectiveness (Phase 2)Looking for participantsNCT06947811
What this trial is testing

Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations

Who this might be right for
EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
Sun Yat-sen University 71
Next Page